Views & Analysis Transparently opaque: drug list prices versus net prices The pros and cons of keeping drug pricing agreements confidential.
News MSD says subcutaneous Keytruda matches IV form A subcutaneous formulation of MSD's top-selling cancer immunotherapy Keytruda was non-inferior to the current intravenous version in a head-to-head trial, setting up regulatory filings.
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
